Denmark's central bank cuts growth outlook citing US tariffs, pharmaceuticals slowdown

Denmark's central bank, Nationalbanken, significantly revised down its GDP growth forecasts for 2025-2027, attributing the cuts to the negative impact of U.S. trade tariffs on global trade and an expected slowdown in the domestic pharmaceutical industry. Projections for 2025 were lowered to 2% from 3.6%, 2026 to 2% from 2.3%, and 2027 to 1.7% from 2%, reflecting concerns over increased competition affecting major players like Novo Nordisk.

Analysis

Denmark's central bank has significantly downgraded its GDP growth forecasts, signaling a deteriorating economic outlook. The projection for 2025 has been slashed to 2.0% from 3.6%, with more moderate cuts for 2026 (to 2.0% from 2.3%) and 2027 (to 1.7% from 2.0%). The central bank attributes this revision to two primary factors: the dampening effect of U.S. trade tariffs on global trade and an anticipated slowdown in the country's pivotal pharmaceutical industry. This pharma weakness is exemplified by the severe downturn at Novo Nordisk, which has faced stalling sales growth, profit warnings, and a staggering $400 billion collapse in its share price amid rising competition for its key weight-loss drug, Wegovy. The company's subsequent layoffs of 9,000 employees, more than half of whom are in Denmark, underscore the material impact of its struggles on the domestic economy.

Key Decisions for Investors

• Investors should re-evaluate exposure to the broader Danish market, as the significant GDP forecast downgrade signals heightened macroeconomic risk driven by both external trade friction and a key internal industry's slowdown.
• Extreme caution is warranted for positions in Novo Nordisk (NVOH), as the report confirms fundamental deterioration with stalling growth and profit warnings directly linked to intensifying competition.
• Monitor developments in U.S. trade policy and competitive data within the weight-loss drug market, as these are the two primary negative catalysts identified by Denmark's central bank.